DE LUCA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 20.700
EU - Europa 10.345
AS - Asia 9.749
SA - Sud America 1.233
Continente sconosciuto - Info sul continente non disponibili 361
AF - Africa 175
OC - Oceania 71
Totale 42.634
Nazione #
US - Stati Uniti d'America 20.358
GB - Regno Unito 4.084
SG - Singapore 2.794
CN - Cina 2.695
IT - Italia 2.281
HK - Hong Kong 1.370
BR - Brasile 954
SE - Svezia 858
VN - Vietnam 839
DE - Germania 629
FI - Finlandia 480
UA - Ucraina 456
BD - Bangladesh 418
TR - Turchia 367
FR - Francia 358
RU - Federazione Russa 319
KR - Corea 311
IN - India 197
CA - Canada 185
BG - Bulgaria 168
SI - Slovenia 166
JP - Giappone 138
ID - Indonesia 131
NL - Olanda 129
AR - Argentina 87
MX - Messico 74
PL - Polonia 73
IQ - Iraq 65
ZA - Sudafrica 62
AE - Emirati Arabi Uniti 52
ES - Italia 51
IE - Irlanda 49
PK - Pakistan 49
EC - Ecuador 45
CO - Colombia 42
BE - Belgio 40
IR - Iran 39
CL - Cile 38
AU - Australia 37
AT - Austria 36
NZ - Nuova Zelanda 34
PH - Filippine 33
UZ - Uzbekistan 33
SA - Arabia Saudita 30
TW - Taiwan 30
CZ - Repubblica Ceca 27
LT - Lituania 27
MA - Marocco 26
MY - Malesia 26
VE - Venezuela 26
EG - Egitto 22
DK - Danimarca 20
RO - Romania 20
TH - Thailandia 17
DZ - Algeria 16
CR - Costa Rica 15
JO - Giordania 14
QA - Qatar 14
JM - Giamaica 13
KE - Kenya 13
TN - Tunisia 13
CH - Svizzera 12
KZ - Kazakistan 12
PT - Portogallo 12
PY - Paraguay 12
UY - Uruguay 12
IL - Israele 11
NP - Nepal 11
PE - Perù 11
EU - Europa 9
AZ - Azerbaigian 8
NI - Nicaragua 8
AL - Albania 7
DO - Repubblica Dominicana 7
SV - El Salvador 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
ET - Etiopia 6
GT - Guatemala 6
HU - Ungheria 6
KW - Kuwait 6
PS - Palestinian Territory 6
RS - Serbia 6
HN - Honduras 5
MD - Moldavia 5
OM - Oman 5
GR - Grecia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NO - Norvegia 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BO - Bolivia 3
CG - Congo 3
KH - Cambogia 3
LB - Libano 3
LV - Lettonia 3
MN - Mongolia 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 42.244
Città #
Southend 3.199
Santa Clara 1.881
Ashburn 1.847
Singapore 1.623
Fairfield 1.552
Hong Kong 1.342
Woodbridge 1.321
Chandler 1.029
Houston 1.003
Jacksonville 963
San Jose 878
Hefei 772
Dearborn 695
Ann Arbor 620
Wilmington 578
Cambridge 561
Seattle 553
Council Bluffs 504
Beijing 491
London 441
Nyköping 385
Sunnyvale 375
Los Angeles 362
Helsinki 309
The Dalles 280
Seoul 253
Ho Chi Minh City 250
Milan 222
Hanoi 217
Modena 213
New York 199
Chicago 193
San Diego 184
Izmir 180
Princeton 180
Sofia 166
Columbus 162
Eugene 151
Lauterbourg 140
Rome 140
Des Moines 125
Buffalo 123
Bologna 108
Bari 102
Moscow 96
Shanghai 90
Jakarta 86
São Paulo 83
Redwood City 82
Falls Church 81
Munich 80
Dallas 76
Salt Lake City 70
Tokyo 66
Boardman 61
Phoenix 57
Orem 51
Norwalk 47
Frankfurt am Main 46
Warsaw 40
Atlanta 39
Bremen 39
Dublin 38
Toronto 38
Brooklyn 37
Guangzhou 37
Haiphong 36
Tampa 33
Kent 32
Elk Grove Village 30
Brasília 29
Montreal 29
Auckland 28
Changsha 28
Da Nang 28
Xi'an 28
Belo Horizonte 27
Brussels 27
Chennai 27
Nanjing 27
Rio de Janeiro 27
Tashkent 27
Formigine 26
Paris 26
Reggio Emilia 26
Baghdad 25
Denver 25
Mexico City 25
Miano 25
Naples 25
Amsterdam 24
Falkenstein 24
Glasgow 24
Catania 23
Johannesburg 23
Turin 23
Campinas 22
Dhaka 22
San Francisco 22
Kunming 21
Totale 29.106
Nome #
Regeneration of the entire human epidermis using transgenic stem cells 927
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 602
Epithelial stem cells in corneal regeneration and epidermal gene therapy 574
Holoclar: first of its kind in more ways than one 540
Applicazioni cliniche dei cheratinociti umani normali coltivati in vitro 487
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 447
Comparative assessment of cultures from oral and urethral stem cells for urethral regeneration 434
Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides 433
Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine 394
Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa 391
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 388
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 384
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 378
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 376
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 368
Advances in Gene/Cell Therapy in Epidermolysis Bullosa 362
Polarized expression of integrin receptors (a6b4, a2b1, a3b1, avb5) and their relationshipwith the cytoskeleton and basement membrane matrix in cultured human keratinocytes. [5YIF: 10.77; Citations: 127] 357
Advances in stem cell research and therapeutic development 356
A volume-sensitive chloride conductance revealed in cultured human keratinocytes by 36Cl- efflux and whole-cell patch clamp recording 353
Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes 348
Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa 342
Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency 333
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 333
"HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis 332
Q-FIHC: Quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells 320
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union 319
The long and winding road that leads to a cure for epidermolysis bullosa 314
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. [5YIF: 3.60, Citations: 215] 313
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 311
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 309
Methods for characterization/manipulation of human corneal stem cells and their applications in regenerative medicine. 309
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 307
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 304
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 303
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 302
A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status 302
Inherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography 300
Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. 299
Gene therapy approaches for epidermolysis bullosa 297
Chloride transport pathways in human keratinocytes 297
Clonal analysis of human clonogenic keratinocytes 297
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa 296
Corrective transduction of human epidermal stem cells in laminin-5-dependent Junctional Epidermolysis Bullosa. 294
Stem cell plasticity: time for a reappraisal? 292
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 291
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 287
Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors 284
A discussion on cell therapy in Manchester 281
p63 identifies keratinocyte stem cells 278
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia 278
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies 276
In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors 275
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls 275
Cell biology: Dormant and restless skin stem cells 271
Corneal Bioengineering 271
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1 266
Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. 265
Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis 264
Topography and biological role of integrins in human skin 264
Characterization of chloride transport pathways in cultured human keratinocytes 264
Eyes on the prize: Limbal stem cells and corneal restoration 262
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors 262
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis 261
Gene therapy of inherited skin adhesion disorders: a critical overview 260
HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation 260
Treatment of 'stable' vitiligo by Timedsurgery transplantation of cultured epidermal autografts 258
Limbal stem-cell therapy and long-term corneal regeneration. 257
Towards a gene therapy clinical trial for epidermolysis bullosa 253
Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing 252
Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes 252
Analysis of the mechanical properties of in vitro reconstructed epidermis: preliminary results 249
The importance of epidermal stem cells in keratinocyte-mediated gene therapy 245
Stamina therapies: Let the record stand 245
[Inhibition of the biosynthesis of thyroglobulin with propranolol in the rat] 243
Advances on potential therapeutic options for epidermolysis bullosa 243
Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes 242
High expression levels of the "erythroid/brain" type glucose transporter (GLUT1) in the basal cells of human eye conjunctiva and oral mucosa reconstituted in culture 242
Regeneration of squamous epithelia from stem cells of cultured grafts 241
Ocular Albinism: evidence for a defect in an intracellular signal transduction system. 239
The Ocular Albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. 239
Effective retrovirus-mediated gene transfer in normal and mutant human melanocytes 238
Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. 237
Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study 235
Towards therapeutic application of ocular stem cells 234
Clonal analysis of stably transduced human epidermal stem cells in culture. 234
Structural and functional studies of integrin receptors in cultured human keratinocytes 232
Isoforms of ΔNp63 and the migration of ocular limbal cells in human corneal regeneration 231
Stairways to Advanced Therapies for Epidermolysis Bullosa 229
Cultivation of human keratinocyte stem cells: current and future clinical applications 227
CRYOPROTECTIVE AQUEOUS SOLUTIONS USEFUL FOR THE PRESERVATION OF IN VlTRO CULTURED EPITHELIAL SHEETS 225
Transforming Growth-Factor-Beta-1 Modulates Beta-1 And Beta-5 Integrin Receptors And Induces The De-Novo Expression Of The Alpha-V-Beta-6 Heterodimer In Normal Human Keratinocytes - Implications For Wound-Healing. 224
[Inhibition of the biosynthesis of thyroglobulin in the thyroid gland of rats by isoniazid] 224
Toward gene therapy of junctional epidermolysis bullosa (JEB) 223
Permanent coverage of full skin thickness burns with autologous cultured epidermis and reepithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: a multicentre study in the treatment of children 223
Expression, topography and function of integrin receptors is severely altered in keratinocytes from involved and uninvolved psoriatic skin. 222
sAPP as a regulator of dendritic motility and melanin release in epidermal melanocytes and melanoma cells. 222
Cryoprotective aqueous solutions useful for the preservation of in vitro cultured epithelial cells. 218
Nerve growth factor (NGF) binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. 217
A multicenter experience in the treatment of burns with autologous and allogeneic cultured epithelium fresh or preserved in a frozen state 217
Biochemical role of FOXM1-dependent histone linker H1B in human epidermal stem cells 214
Totale 30.245
Categoria #
all - tutte 155.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.688 0 0 238 284 141 250 202 173 345 218 471 366
2022/20233.174 369 339 333 233 365 475 69 285 424 43 140 99
2023/20242.028 76 128 123 159 387 128 119 271 55 225 83 274
2024/20257.304 254 98 175 478 1.276 1.146 570 379 683 271 913 1.061
2025/202611.743 759 658 983 1.073 1.231 941 1.540 624 1.182 1.183 762 807
2026/20271.789 431 1.307 51 0 0 0 0 0 0 0 0 0
Totale 42.634